肥胖和内脏脂肪会导致心力衰竭吗?
1Baylor Heart and Vascular Institute, Baylor University Medical Center, 621 North Hall Street, Dallas, TX 75226, USA.
European heart journal
|September 2, 2025
概括
肥胖对心力衰竭有显著影响,但其对心力衰竭的作用尚不清楚. 过多的内脏脂肪与HFpEF有关,而与HFrEF的关联需要进一步调查.
科学领域:
- 心脏病学
- 代谢综合征
- 肥胖研究
背景情况:
- 肥胖和内脏脂肪是心力衰竭的关键因子.
- 相比之下,肥胖不是早期心力衰竭与减少喷射率 (HFrEF) 研究的突出特征,甚至被认为是保护性的.
- 中部脂肪预测HFpEF的发展,但在一般人群中没有HFrEF.
研究的目的:
- 研究肥胖和内脏脂肪在HFpEF与HFrEF发病和进展中的不同作用.
- 探索脂肪标志物,全身炎症和心力衰竭亚型之间的关系.
- 评估肥胖对HFpEF和HFrEF治疗反应的影响.
主要方法:
- 在HFpEF和HFrEF队列中对肥胖和脂肪标志物的比较分析 (腰与身高的比,心上脂肪组织).
- 与心力衰竭类型相关的全身炎症标志物 (hsCRP) 和皮素 (叶丁,皮素) 的评估.
- 根据肥胖状况对治疗反应的评估 (矿物质皮质类受体抗剂,尼普利辛抑制剂,SGLT2抑制剂,基于基的药物).
主要成果:
- 心上脂肪组织的扩张和腰部与身高的比率的增加与HFpEF有关,而心上脂肪的减少与HFrEF预后的恶化有关.
- 高hsCRP预测HFpEF的发展,可能是由于脂肪驱动的炎症,与HFrEF不同,它可能与动脉样硬化或阻塞有关.
- 肥胖不同于HFpEF (由脂肪驱动) 和HFrEF (由心脏/神经激素信号驱动) 的影响.
- 中部肥胖症患者可能会对HFpEF和HFrEF的某些疗法产生反应,但治疗疗效因HF类型而异.
结论:
- 肥胖和内脏脂肪是HFpEF的基本驱动因素,与HFrEF相比具有不同的病理生理作用.
- 肥胖标志物和相关炎症提供了对HFpEF和HFrEF的差异见解.
- 了解肥胖在HFrEF中的作用对于完善治疗策略和改善患者结果至关重要.
相关概念视频
Pathophysiology of Heart Failure
1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Heart Failure I: Introduction
52
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
52
Heart Failure II: Pathophysiology
37
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
37
Heart Failure IV: Classification and Diagnostic Evaluation
32
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
32
Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Heart Failure III: Clinical Manifestations
42
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
42


